# A Study of MHB046C Injection in Patients With Advanced Solid Tumors

> **NCT06985355** · PHASE1,PHASE2 · RECRUITING · sponsor: **Minghui Pharmaceutical (Hangzhou) Ltd** · enrollment: 200 (estimated)

## Conditions studied

- Advanced Solid Cancer

## Interventions

- **DRUG:** MHB046C

## Key facts

- **NCT ID:** NCT06985355
- **Lead sponsor:** Minghui Pharmaceutical (Hangzhou) Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-17
- **Primary completion:** 2029-05
- **Final completion:** 2031-05
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06985355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06985355, "A Study of MHB046C Injection in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06985355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*